Brief: Bvf Partners LP Says Rain Therapeutics Securities Were "Undervalued"
April 28 (Reuters) - Rain Therapeutics Inc RAIN.O :
* BVF PARTNERS LP SAYS PURCHASED RAIN THERAPEUTICS
SECURITIES
BASED ON BELIEF THAT SUCH SECURITIES, WHEN PURCHASED, WERE
"UNDERVALUED" - SEC FILING
* BVF PARTNERS LP SAYS IT BENEFICIALLY OWNS 1.85 MILLION
SHARES OF
COMMON STOCK IN RAIN THERAPEUTICS INC
* BVF PARTNERS LP SAYS ITS STAKE HOLDING IN RAIN
THERAPEUTICS INC,
EXCLUDES 3.3 MILLION SHARES OF UNDERLYING NON-VOTING COMMON
STOCK
Source text : (https://bit.ly/3ns1XFM)
Further company coverage: RAIN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rain Oncology
See all newsBrief: Rain Enhancement Technologies Holdco - May Offer Up To $25 Million In Securities From Time To Time - SEC Filing
Brief: Rain Enhancement Technologies Holdco Inc - Q1 And Q2 2025 Financial Statements Should Not Be Relied Upon Due To Accounting Error - SEC Filing
Brief: Rain Oncology Pursuant To Proposed Deal With Pathos AI
Brief: Rain Oncology To Be Acquired By Pathos AI For $1.16 In Cash Per Share Plus Contingent Value Rights
Brief: Rain Oncology Q3 Net Income USD -7.034 Million